Related Experiment Video
Updated: May 13, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Intermediate-fraction neoadjuvant radiotherapy for rectal cancer
Tiancheng Zhan1, Jin Gu, Ming Li
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Colorectal Surgery, Peking University Cancer Hospital & Institute, Beijing, China.
Diseases of the Colon and Rectum
|March 13, 2013
Summary
A modified neoadjuvant radiation regimen in China significantly reduced local recurrence and improved survival for rectal cancer patients. This approach offers comparable outcomes to standard treatments, providing a more accessible option.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Standard neoadjuvant chemoradiation therapy is poorly accepted in China due to cost and long duration.
- Rectal cancer treatment requires effective neoadjuvant strategies tailored to local constraints.
Purpose of the Study:
- To evaluate the impact of a modified neoadjuvant radiation regimen on rectal cancer patient prognosis in China.
- To assess the efficacy and safety of a shortened preoperative radiotherapy protocol.
Main Methods:
- A nonrandomized cohort study compared patients who received a modified preoperative radiotherapy (30 Gy in 10 fractions) versus those who did not.
- Included locally advanced, mid-to-low rectal cancer patients undergoing total mesorectal excision.
- Analyzed local recurrence, distant metastases, disease-free survival, and overall survival using Kaplan-Meier analysis.
Main Results:
- The modified regimen achieved a 50% TNM downstaging rate and a complete response in 5% of patients.
- Local recurrence was significantly lower in the radiotherapy group (5%) compared to controls (18%, p=0.02).
- Patients with downstaging in the radiotherapy group showed improved 5-year disease-free and overall survival rates.
Conclusions:
- The modified neoadjuvant radiation regimen is associated with reduced local recurrence and improved survival in rectal cancer patients with downstaging.
- This protocol offers clinical outcomes equivalent to standard neoadjuvant procedures, providing a flexible alternative for Chinese patients.
- Potential bias exists due to non-randomization and patient self-selection based on financial means.
